REGN
Regeneron Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$827.72
−1.87%Forward multiples
Based on analyst estimates
- P/E forward
- 13.66x
- P/E 2026E
- 15.39x
- P/E 2027E
- 13.71x
- P/E 2028E
- 12.27x
- P/S forward
- 4.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.76x
- PEG TTM
- 0.45x
- Price / book
- 2.69x
- Price / sales
- 5.49x
- Price / cash flow
- 19.18x
Enterprise value
- Enterprise value
- $79.2B
- EV / sales
- 5.10x
- EV / EBITDA
- 13.78x
- EV / EBIT
- 19.95x
- Market cap
- $85.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026